This article is more than 5 years old. Information may no longer be current.

FMT may be safe for immunocompromised patients with C. difficile

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO – Colleen Kelly, MD, clinical assistant professor of medicine at Brown Alpert School of Medicine in Providence, R.I., discusses her presentation, "Fecal Microbiota Transplantation (FMT) for Treatment of Clostridium difficile Infection (CDI) in Immunocompromised Patients," at the American College of Gastroenterology Annual Scientific Meeting.

In a retrospective study of 61 adult and five pediatric patients with C. difficile infection treated with FMT, the researchers observed an 89% overall cure rate, with few related or serious adverse events and no infectious complications.